Search Results - "Noordhoek, Iris"

Incidence and clinical relevance of cage subsidence in anterior cervical discectomy and fusion: a systematic review by Noordhoek, Iris, Koning, Marvyn T., Jacobs, Wilco C. H., Vleggeert-Lankamp, Carmen L. A.

“…Background The placement of intervertebral cages in anterior cervical discectomy (ACDF) supposedly maintains foraminal height. The most commonly reported…”
Get full text

Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results From the INSPIRE Registry by Esgueva, Antonio J., Noordhoek, Iris, Kranenbarg, Elma Meershoek-Klein, Espinosa-Bravo, Martin, Mátrai, Zoltán, Zhygulin, Andrii, Irmejs, Arvids, Mavioso, Carlos, Meani, Francesco, González, Eduardo, Özdemir, Murat, Allweis, Tanir, Rogowski, Karol, dos Santos, Catarina Rodrigues, Mora, Henrique, Ponzone, Riccardo, Samorani, Domenico, van de Velde, Cornelis, Audisio, Riccardo A., Rubio, Isabel T.

“…Introduction Nipple-sparing mastectomy (NSM) with immediate breast reconstruction (IBR) is increasingly used for both breast cancer (TNSM) and risk reduction…”
Get full text

ASO Visual Abstract: Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results from the INSPIRE Registry by Esgueva, Antonio J., Noordhoek, Iris, Kranenbarg, Elma Meershoek-Klein, Espinosa-Bravo, Martin, Mátrai, Zoltán, Zhygulin, Andrii, Irmejs, Arvids, Mavioso, Carlos, Meani, Francesco, González, Eduardo, Özdemir, Murat, Allweis, Tanir, Rogowski, Karol, dos Santos, Catarina Rodrigues, Mora, Henrique, Ponzone, Riccardo, Samorani, Domenico, van de Velde, Cornelis, Audisio, Riccardo A., Rubio, Isabel T.

Get full text

Magnetic Marker Localization for Non-Palpable Breast Cancer Using the Magseed and Sentimag Systems by Noordhoek, Iris, van der Hage, Jos

Get full text

Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR + Early-stage Breast Cancer for 10 Years of Endocrine Therapy by Noordhoek, Iris, Treuner, Kai, Putter, Hein, Zhang, Yi, Wong, Jenna, Meershoek-Klein Kranenbarg, Elma, Duijm-de Carpentier, Marjolijn, van de Velde, Cornelis J H, Schnabel, Catherine A, Liefers, Gerrit-Jan

“…Individualized selection of patients with early-stage hormone receptor-positive (HR ) breast cancer for extended endocrine therapy (EET) is required to balance…”
Get full text

Breast Cancer Index and prediction of benefit from extended endocrine therapy based on treatment compliance: An IDEAL study by Liefers, Gerrit-Jan, Noordhoek, Iris, Treuner, Kai, Putter, Hein, Wong, Jenna, Zhang, Yi, Meershoek – Klein Kranenbarg, Elma, Van De Velde, Cornelis J.H., Schnabel, Catherine A.

“…Abstract only 531 Background: The IDEAL trial randomized hormone receptor-positive (HR+) breast cancer patients to 5 vs 2.5y of extended letrozole after…”
Get full text

Reply to M. Dowsett et al by Noordhoek, Iris, Putter, Hein, Portielje, Johanneke E A, Liefers, Gerrit-Jan

Get full text

Predictive performance of breast cancer index (BCI) and clinical treatment score post-5 years (CTS5) in the IDEAL study by Liefers, Gerrit-Jan, Noordhoek, Iris, Putter, Hein, Wong, Jenna, Siuliukina, Natalia, Zhang, Yi, Meershoek – Klein Kranenbarg, Elma, Duijm-de Carpentier, Marjolijn, Van De Velde, Cornelis J.H., Schnabel, Catherine A., Treuner, Kai

“…545 Background: The Breast Cancer Index (BCI) is a gene expression–based signature that stratifies patients based on the risk of overall (0-10y) and late…”
Get full text

Breast cancer index (BCI) predicts benefit of two-and-a-half versus five years of extended endocrine therapy in HR+ breast cancer patients treated in the ideal trial by Liefers, Gerrit-Jan, Noordhoek, Iris, Treuner, Kai, Putter, Hein, Zhang, Yi, Meershoek – Klein Kranenbarg, Elma, Wong, Jenna, Van De Velde, Cornelis J. H., Schnabel, Catherine A.

“…Abstract only 512 Background: For postmenopausal women with hormone receptor positive (HR+) breast cancer, the optimal duration of extended endocrine therapy…”
Get full text

Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials by Noordhoek, Iris, Blok, Erik J, Meershoek-Klein Kranenbarg, Elma, Putter, Hein, Duijm-de Carpentier, Marjolijn, Rutgers, Emiel J T, Seynaeve, Caroline, Bartlett, John M S, Vannetzel, Jean-Michel, Rea, Daniel W, Hasenburg, Annette, Paridaens, Robert, Markopoulos, Christos J, Hozumi, Yasuo, Portielje, Johanneke E A, Kroep, Judith R, van de Velde, Cornelis J H, Liefers, Gerrit-Jan

“…Most distant recurrences (DRs) in women with hormone receptor-positive breast cancer occur after 5 years from diagnosis. The Clinical Treatment Score post-5…”
Get full text

Abstract PS6-06: The 70-gene signature (MammaPrint) accurately predicts distant breast cancer recurrence risk in patients aged ≥70 years from the population-based observational FOCUS cohort by Noordhoek, Iris, Bastiaannet, Esther, Lujinovic, Ersan, Esserman, Laura, Wesseling, Jelle, Scholten, Astrid, Schröder, Carolien P, Elias, Sjoerd, de Glas, Nienke A, Kroep, Judith R, Portielje, Johanneke EA, Kleijn, Miranda, Liefers, Gerrit-Jan J

“…Abstract Background Predicting breast cancer recurrence in patients aged ≥70 years is challenging, as they generally have more indolent tumors and a higher…”
Get full text

Abstract PD2-11: Breast cancer index is a molecular signature of endocrine responsiveness that determines extended endocrine benefit independent of prognostic risk by Liefers, Gerrit-Jan, Noordhoek, Iris, Treuner, Kai, Putter, Hein, Zhang, Yi, Wong, Jenna, Kranenbarg, Elma Meershoek-Klein, Duijm-de Carpentier, Marjolijn, Van De Velde, Cornelis JH, Schnabel, Catherine A

“…Abstract Background: For patients with early stage, hormone receptor positive (HR+) breast cancer, extension of endocrine therapy beyond 5 years reduces the…”
Get full text

Integrin regulation by tissue factor promotes cancer stemness and metastatic dissemination in breast cancer by Ünlü, Betül, Kocatürk, Begüm, Rondon, Araci M. R., Lewis, Clayton S., Swier, Nathalie, van den Akker, Rob F. P., Krijgsman, Danielle, Noordhoek, Iris, Blok, Erik J., Bogdanov, Vladimir Y., Ruf, Wolfram, Kuppen, Peter J. K., Versteeg, Henri H.

“…Tissue Factor (TF) is the initiator of blood coagulation but also functions as a signal transduction receptor. TF expression in breast cancer is associated…”
Get full text

International comparison of treatment and survival of older patients with primary metastatic breast cancer (PMBC) – a population-based cohort study from the EURECCA Breast Cancer Group by Noordhoek, Iris, Bastiaannet, Esther, van Eycken, Liesbet, Siesling, Sabine, Walsh, Paul, Johannesen, Tom, Portielje, Johanneke, van de Velde, Cornelis

Get full text

Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial by Vliek, Sonja B, Noordhoek, Iris, Meershoek-Klein Kranenbarg, Elma, van Rossum, Annelot G J, Dezentje, Vincent O, Jager, Agnes, Hokken, J W Esmeralda, Putter, Hein, van der Velden, Annette W G, Hendriks, Mathijs P, Bakker, Sandra D, van Riet, Yvonne E A, Tjan-Heijnen, Vivianne C G, Portielje, Johanneke E A, Kroep, Judith R, Nortier, Johan W R, van de Velde, Cornelis J H, Linn, Sabine C

“…For postmenopausal patients with breast cancer, previous subgroup analyses have shown a modest benefit from adjuvant bisphosphonate treatment. However, the…”
Get full text

Correction: Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results From the INSPIRE Registry by Esgueva, Antonio J., Noordhoek, Iris, Kranenbarg, Elma Meershoek-Klein, Espinosa-Bravo, Martin, Mátrai, Zoltán, Zhygulin, Andrii, Irmejs, Arvids, Mavioso, Carlos, Meani, Francesco, González, Eduardo, Özdemir, Murat, Allweis, Tanir, Rogowski, Karol, dos Santos, Catarina Rodrigues, Mora, Henrique, Ponzone, Riccardo, Samorani, Domenico, van de Velde, Cornelis, Audisio, Riccardo A., Rubio, Isabel T.

Get full text

Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study by Noordhoek, Iris, Bastiaannet, Esther, de Glas, Nienke A., Scheepens, Josien, Esserman, Laura J., Wesseling, Jelle, Scholten, Astrid N., Schröder, Carolien P., Elias, Sjoerd G., Kroep, Judith R., Portielje, Johanneke E.A., Kleijn, Miranda, Liefers, Gerrit-Jan

“…When risk estimation in older patients with hormone receptor positive breast cancer (HR + BC) is based on the same factors as in younger patients, age-related…”
Get full text

Preliminary results of the international nipple sparing mastectomy registry – a EURECCA project by Noordhoek, Iris, Bastiaannet, Esther, Meershoek-Klein Kranenbarg, Elma, Espinosa-Bravo, Martin, Mátrai, Zoltán, Zhygulin, Andrii, Irmejs, Arvids, Mavioso, Carlos, Meani, Francesco, González, Eduardo, Yeniay, Levent, Allweis, Tanir, Rogowski, Karol, Rodrigues dos Santos, Catarina, Mora, Henrique, Ponzone, Riccardo, Samorani, Domenico, van de Velde, Cornelis, Audisio, Riccardo, Rubio, Isabel

Get full text

Improving hormonal therapy: to extend, to intermit, or to readjust expectations? by Noordhoek, Iris, Bastiaannet, Esther, van de Velde, Cornelis J. H.

Get full text